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The effect of food elimination and probiotic supplementation in asthmatic children 
with food allergy 
 
INTRODUCTION 
Both bronchial asthma and food allergy show 
increase in prevalence worldwide, this makes the 
management of children with food allergy and 
asthma a growing concern.1 Population studies have 
shown that an early food sensitization or food 
allergy in the first year of life may precede the 
development of asthma.2,3 When asthma and food 
allergy coexist, they adversely influence the course 
of each other. Asthma attack can be elicited by food 
allergens in sensitized children.4 
The cornerstone of the nutritional management 
of food allergies is an individualized allergen 
avoidance management plan. In children, the main 
goals are to prevent the occurrence of acute and 
chronic symptoms by avoiding the offending 
food(s), whilst providing an adequate, healthy and 
nutritionally balanced diet and maintaining optimal 
growth.5 
The role of the intestinal microbiota in the 
development of immune tolerance to food is 
increasingly appreciated. The commensal gut 
microbiota targets different cellular components of 
the innate and adaptive immune compartments to 
promote oral tolerance.6 One mechanism by which 
the commensal microbiota influences the outcome 
of the allergic response is by modulating the innate 
lymphoid cells (ILC) to secrete IL-12. The 
commensal microbiota also targets the adaptive 
immune response to promote tolerance through 
promoting the differentiation of induced T 
regulatory (iTreg) cells from naive CD4+ T cell.7 
Probiotics are living bacteria intended to have 
health benefits, they are not only a driver of growth 
but also a modulator of the immune system and 
prevention of many diseases.8,9,10 The most 
commonly used probiotics are the strains of lactic 
acid bacteria such as Lactobacillus, 
Bifidobacterium and Streptococcus (S.) 
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thermophilus. Other organisms including 
Enterococci and yeasts have also been used as 
probiotics. Specifically, important, probiotics can 
induce a milieu of tolerogenic immune responses to 
food.11  
In this work we aimed to detect the prevalence 
of food allergy in children with bronchial asthma, 
the effect of elimination of food allergens on the 
clinical outcome of asthma and the quality of life of 
these children and, also, we aimed to detect the 
effect of probiotic supplementation on quality of 
life and clinical manifestation in these children.  
 
METHODS 
The study was held in Allergy and Immunology Unit 
(the unit deals with both adult and pediatric allergic 
patients), Medical Microbiology and Immunology and 
Pediatric departments, Faculty of Medicine, Zagazig 
University from June 2019 to September 2020.The 
Institutional review board approved the study 
according to the ethical principle of the declaration of 
Helsinki, written informed consent was taken from 
patients. The IRB approval number was 5390. 
This randomized controlled interventional study 
included 226 consecutively recruited children aged 
from 4 to 18 years, suffering from bronchial asthma 
from pediatric outpatient clinic (Diagnosis was based 
on GINA guidelines)12, patients with different grades 
of asthma and different levels of control were 
included. From among these children, those who had 
associated food allergy were included in the study.  
Food allergy was first suspected by history, then 
food sensitization was indicated by the presence of 
specific IgE (detected either by skin prick test or by 
serum specific IgE). Food allergy confirmed 
diagnosis was based on oral food challenge test.  
Exclusion criteria were children less than two 
years, those who had received immunosuppressants, 
antibiotics, systemic corticosteroids within 4 weeks, 
children who had immunodeficiency disease, 
children who used probiotic preparations within 4 
weeks, those suffering from broncho-pulmonary 
disorders or infectious diseases, non-cooperative 
patients and patients who had received 
immunotherapy before the start of the study. 
 
Study design 
Patients who suffered from both bronchial asthma 
and food allergy were randomized in four different 
groups depending on a blind selection of colored 
cards, yellow for group I and green for group II, red 
for group III and blue for group IV. Each group 
comprised 22 patients as follows: group (1): were 
given pharmacological treatment only; group (2): 
were given pharmacological treatment and probiotic 
supplementation; group (3): practiced food 
elimination and received pharmacotherapy, and 
group (4): practiced food elimination and received 
probiotic supplementation and pharmacological 
therapy. 
 Patients were followed up after 3 months to step 
up or stepdown treatment according to deterioration 
or improvement of symptoms, then another final 
assessment was done after 6 months of study.  
 
Asthma severity grading 
Patients were classified in all four groups into 
intermittent, mild persistent, moderate persistent, 
and severe persistent according to symptoms, 
nighttime awakening, drugs used, interfering with 
normal activity, lung function.13 Initial grading was 
done at the beginning of the study, patients were 
followed up at 3 months and then at 6 months for 
final grading and this was used to compare with the 
grading at the initial presentation. 
 
Total IgE assay 
Total serum IgE levels were measured using 
commercially available kits (Biocheck Total IgE 
kit) from Biokit (South San Francisco, CA 94080). 
It was done for the four groups according to the 
manufacturer guidelines. The minimum detectable 
concentration of IgE by this assay is estimated to be 
5.0 IU/ml  
 
Pediatric Asthma quality of life questionnaire 
(PAQLQ) 
This questionnaire used for following up at baseline 
and after 6 months. The questionnaire was in 
standardized Arabic version supplied by Elizabeth 
Juniper (MCSP, MSc, Professor, England, received 
by mail) and filled by the parents of children.  It 
included 23 questions to assess activity and quality 
of life of these children as questions 
4,6,8,10,12,14,16,18,20 and 23 were about 
symptoms, questions 1,2,3,19 and 22 were about 
activity while questions 5,7,9,11,13,15,17 and 21 
asked about emotional effect. High score of the 
questionnaire indicated better control of asthma and 
better quality of life. 
 
Detection of specific IgE for food allergens 
Prick to Prick test was done unless patients suffered 
from unstable asthma, un-cooperative children or 
parents’ preference of serum specific IgE assay. 
A) Prick to prick skin testing: The food used for 
testing fruit and vegetables should be fresh (not 
tinned or cooked in order not to alter 
allergenicity). For fruit / vegetables a lancet was 
pushed into fleshy part of the food then a small 
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amount of the food substance was placed onto 
the skin. Then lancet was pushed through the 
surface layer of the skin with an angle of  90 
angle through the food. For foods like peanut; it 
was grinded to make a paste using sterile saline, 
the tip of the  lancet was put in this paste and  a 
small part of the paste was placed on the skin 
before pricking through it with the lancet.14 The 
test was done according to the recommendations 
of European society of Allergy and Clinical 
Immunology (EAACI); the negative control was 
saline solution and the positive control was 
histamine dihydrochloride (10mg/ml) 
(Omegadiagnostic, Canada), positive test was 
considered when the test material produced a 
wheal >3mm above the wheal produced by the 
negative control.15 Determination of the type of 
the food used in the test was based on careful 
history taking.  
B) Serum specific IgE assay for food allergen 
(AllergyScreen / AlleisaScreen Spec. IgE) made 
in Germany. Immunblot assay for the 
quantitative determination of specific IgE in 
human serum. It was done for groups III and IV. 
Interpretation of the results were based on:  none 
found or hardly exists: <0.35 IU/ml, Low: 0.35-
0.69 IU/ml, Increased: 0.70-3.49 IU/ml, 
Significantly increased: 3.50-17.49 IU/ml, High: 
17.50-49.99 IU/ml, Very high: 50.00-100 IU/ml, 
and extremely high: >100.00 IU/ml. 
 
Food elimination 
Food elimination was based on detailed history and 
or results of specific IgE detection. For all groups, 
patients suspected to have food allergy by history or 
positive specific IgE, were instructed to eliminate 
this food for 2-4 weeks from their diet. After this 
period food was reintroduced again under medical 
supervision through open oral food challenge test 
(OFC) to confirm food allergy diagnosis.16 Patients 
in group groups III and IV were instructed to avoid 
food which they prove to be allergic for six months 
(the end of the study). 
 
Oral food challenge test (OFC) 
Open OFC test was performed. On the day of the 
test, a child should be in a good health,  chronic 
allergic conditions such as asthma, atopic dermatitis 
(eczema) and allergic rhinitis (hay fever) have to be 
well controlled in order not to interfere with the 
interpretation of any symptoms, and antihistamines 
have to be stopped before the OFC since they might 
mask mild early symptoms. Emergency treatment 
such as epinephrine, antihistamines or inhaled 
asthma rescue medications should be available. The 
test was done according to the EACCI guidelines. 
OFC was preceded by elimination of the suspected 
food. Briefly, children were given increasing 
amount of the tested food, on interval of 25-20 min. 
Doubling of dose continued until the child had the 
regular intake amount. Before each dose all the vital 
signs of the child were recorded and compared with 
the base line measures before the beginning of the 
test. The test was considered positive if allergic 
manifestations were detected after any given dose.17  
 
Probiotic supplementation 
Probiotic supplements containing Lactobacillus 
acidophilus LB Strain 10 billion (Lyophilized 
microbial bodies), Lactose monohydrate, calcium 
carbonate, silicic acid, banana-orange flavour, 
saccharose, q.s. 800mg were given for children in 
groups II and IV.  Children received probiotics as 
one sachet Bid x 2 days, for three months. 
 
Statistical Analysis 
Data collected throughout history, basic clinical 
examination, laboratory investigations and outcome 
measures were coded, entered and analyzed using 
Microsoft Excel software. Data were then imported 
into Statistical Package for the Social Sciences 
(SPSS version 22.0) software for analysis.  For data 
comparison, The Chi square test (X), Kruskal 
Wallis test (K), percentage of change and Fisher 
exact test (F) were used. A p-value equal or less 
than 0.05 was considered significant, highly 




Prevalence of food allergy among asthmatic 
children 
Out of 226 asthmatic children, 88 children had been 
diagnosed with food allergy. Diagnosis of food 
allergy was based on the result of OFC test. The 
prevalence of food allergy in asthmatic children 
was about 38.9%. Detected food allergens were 
cow milk and casein 68 (77%), followed by chicken 
56 (65%), egg 52(59%), banana 52 (59%), fish 52 
(59%), wheat 48(54%) and peanut 28(31%). 
 
Age, sex, Severity of asthma, Quality of life and 
total IgE in the four groups before treatment 
At the beginning of the study, there were no 
statistical significance differences between the 
studied groups regarding age, sex,  severity of 
asthma, total IgE and QOL. (table 1).  
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Severity of asthma, Quality of life and total IgE 
for each group before and after treatment 
There was statistically significant decrease in the 
severity of asthma in all groups except group 1. 
However, IgE levels, and QOL showed high 
statistically significant improvement (Table 2 and 
figure 1). 
 
Severity of asthma, quality of life and total IgE 
among four groups after treatment 
Our results showed that there was a statistically 
significant increase in frequency of mild cases 
among group IV compared to groups I and II.  Total 
IgE level significantly decreased with treatment in 
group IV compared to groups I and II , in group III 
compared to groups I and II and in group II 
compared to group I. There was a statistically 
significant increase in mean QOL score after 
treatment of group IV compared to groups I and II 
and also among group III compared to group I 
(table 3). However, comparing the individual 
categories of Qol regarding scores of symptoms, 
activity and emotion revealed no statistically 
significant difference P >0.05 (table 4). 
 
 
Table 1. Differences in severity of asthma, total IgE and quality of life among four groups before treatment 

































Male: n (%) 














































Mean ± SD 
Range 
 
246.36 ± 292.02 
5 – 970 
 
404 ± 448.94 
7 - 1000 
 
317.73 ± 405.38 
10 – 1000 
 
301.36 ± 383.8 








Mean ± SD 
Range 
 
52.36 ± 5.48 
40 – 60 
 
53.45 ± 3.21 
48 – 59 
 
50 ± 3.66 
43 - 56 
 
49.91 ± 3.94 







SD: Standard deviation, KW: Kruskal Wallis test,  F:Fisher exact test ,  X2: Chi square test; NS: Non-significant (P>0.05) 
 
 
Table 2. Grading of asthma severity pre and post treatment among the studied group. 
Variable Pre-treatment Post-treatment % of change P 
Group I (n=22) 
Mild persistent n (%) 
Moderate persistent n (%) 














Group II (n=22) 
Mild persistent n (%) 
Moderate persistent n (%) 













Group III (n=22) 
Mild persistent n (%) 
Moderate persistent n (%) 
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Group IV (n=22) 
Mild persistent n (%) 
Moderate persistent n (%) 
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Figure 2. QOL score pre- and post-treatment among the studied groups. 
 
Table 3. Severity of asthma, total IgE level, and QOL between four groups after treatment. 











Mild n (%) 
Moderate n (%) 


























Mean ± SD 
Range 
216.82 ± 252.39 
5 – 820 
174.91 ± 178.72 
4 - 540 
119.64 ± 140.25 
2 – 500 
103.18 ± 126.83 






Mean ± SD 
Range 
 
53.09 ± 4.39 
45 – 60 
 
54.55 ± 3.05 
49 – 60 
 
56.09 ± 3.81 
49 – 60 
 
57.90 ± 3.24 




SD: Standard deviation, KW: Kruskal Wallis test, F:Fisher exact test ,  *: significant (P<0.05),  * * : highly significant (P<0.001) 
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Table 4. Changes in symptoms, emotion and activity scores of Qol for the four groups before and after 
treatment 
  Group I t 
P 
Group II t 
P 
Group III t 
P 



























































































P: p value, t: paired t test, NS: non-significant 
 
DISCUSSION 
According to our results, out of 226 asthmatic 
children, 88 children had been diagnosed with food 
allergy, so the prevalence of food allergy in 
asthmatic children was about 38.9%. This study 
was consistent with another study reported that 48% 
of asthmatic patients had food allergy.21 While 
other studies had found that 34% to 78% of 
asthmatic patients complained from food-related 
symptoms.18,19,20,21 Also, Aba-Alkhail and El-
Gamal, reported that the prevalence of clinical 
sensitivity to food was 29%. 22 Moreover, 
Friedlander et al., 2013 prospectively surveyed 300 
asthmatic children, of whom 24% had food allergy 
out of them 12% had multiple food allergies.23 
On the other hand, Krogulska et al, reported that 
IgE-related food allergy was present in 9.8% of 
children with asthma.24 The difference in 
prevalence could be expected as a result of 
difference in food habits, genetic backgrounds and 
environmental conditions among different 
populations. 
 The four study groups were comparable before 
treatment regarding age, gender and severity of 
asthma and QOL. Severe asthma has a great impact 
on the quality of life (QOL) of patients and their 
families. QOL is defined as the perception that 
individuals have of their position in life, in the 
context of the culture and system of values in which 
they live and in relation to their objectives, 
expectations, standards and concerns.25 Before the 
study, total IgE in all four groups ranged from 5 to 
1000 IU/ml. Similar range of serum IgE (5-996) 
IU/ml was also obtained from a previous study on 
Egyptian children.26  
In this study, the standardized questionnaire of 
asthma quality control (PAQLQ) score did not 
differ significantly among the four groups before 
treatment; the ranges were very near for all groups. 
Similar results were obtained when the same 
questionnaire was applied on a random sample of 
Egyptian children where mild cases had scores 
ranging from 41 to 58.27   
Asthma control showed significant improvement 
with treatment in all groups except the group that 
received pharmacological therapy only, (p values 
were 0.45, 0.02, 0.008 and 0.002 respectively), 
where there were increases in the number of mild 
persistent and moderate persistent asthma at the 
expense   of those suffering from severe persistent 
asthma. The lack of statistical significance was 
probably due to small sample size, especially in 
view of the significant improvement of QOL and 
decrease of the total IgE level with treatment. The 
improvement observed in all three parameters of the 
other treatment groups illustrate that 
pharmacological therapy, avoidance of food that 
triggered asthma and the use of probiotics can have 
a significant positive impact on the course of the 
disease and the quality of life of these children. The 
impact of food elimination we obtained in this 
study, is consistent with Giovannini et al., who 
found that the avoidance of the offending food is 
the cornerstone of treatment of IgE mediated food 
allergy.28 Elimination of the offending food must 
take place not only from the diet, but also from the 
environment in which the child lives. Asthmatic 
crises and the use of anti-asthmatic drugs decrease 
when the offending foods are no longer even 
cooked in the domestic environment and decrease 
the level of total IgE.29  
The role of intestinal microbiota in the 
development of the host immune system and the 
induction of immune tolerance have gained much 
interest. Probiotics are considered safe for human 
consumption if sold as dietary supplements 
according to the Food and Drug Administration  
(FDA), as they fall under the broad category of 
food items. Despite the marked rise in food 
allergies and intolerances, probiotics remain 
Food elimination and probiotic supplementation in asthmatic children 
25 
 
underutilized as a treatment despite an emerging 
body of research implicating the critical role of gut 
microbiota and their metabolites in the treatment of 
food allergies and intolerances.30,31  
Asthmatic children who received probiotics 
supplementation and those who practiced food 
elimination and received probiotic showed 
improvement in the studied parameters. This agreed 
with Elazab et al., who found that in asthma, 
treatment with Lactobacillus rhamnosus GG (LGG) 
inhibited inflammatory cell infiltration.32 In 
addition, in OVA-sensitized mice (Ova albumin), 
LGG reduced OVA-specific IgE levels in serum, 
suppressed the airway hyper-responsiveness to 
methacholine and decreased the number of 
infiltrating inflammatory cells and Th2 cytokines 
and IgE level in bronchoalveolar lavage fluid and 
serum.33 This was consistent with the result of Wu 
et al., 2016 who showed that Lactobacilllus gasseri 
A5 showed a significant reduction in symptoms of 
asthma and allergic rhinitis along with 
improvement of pulmonary functions as there was a 
significant reduction in the TNF-α, IFN-γ, IL-12, 
and IL-13 production by the peripheral blood 
mononuclear cells (PBMCs) following the probiotic 
treatment.32,34 
It has been postulated that early exposure to 
commensal bacteria plays a crucial role in Th1/Th2 
polarization and maturation of proper immune 
regulatory mechanisms. Probiotics may modulate 
toll-like receptors and the proteoglycan recognition 
proteins of enterocytes, leading to activation of 
dendritic cells and a Th1 response; the resulting 
stimulation of Th1 cytokines can suppress Th2 
responses.32 It is also suggested that probiotics 
induce a tolerogenic microenvironment and high 
IL-10, this might be employed for oral 
immunotherapy (OIT) ) to treat allergy and 
autoimmunity in the future.35,36,37  
With respect to the effect of treatment, we found 
that children who received all suggested lines of 
treatment (pharmacological therapy, food 
elimination and probiotic supplementation), showed 
the best outcome, followed by those who received 
pharmacological therapy and practiced food 
elimination then children who received 
pharmacological therapy and probiotic 
supplementation . Results herein intensify the 
importance of diagnosis of food allergy in asthmatic 
children which seems to be a common comorbidity 
and uniquely encourage combining 
pharmacological therapy, avoidance of the offended 
food allergen and intake of probiotic to make a 
significant improvement in the quality of life of 
pediatric population suffer from bronchial asthma. 
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